Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

3(50.0%)

Phase 2

2(33.3%)

Phase 3

1(16.7%)

6Total

Phase 1(3)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07435922Not Yet Recruiting

Evaluate Recombinant Human Serum Albumin From Oryza Sativa In Patients With Hypoalbuminemia and/or Hypovolemia Requiring Urgent Treatment

Role: lead

NCT06722664Phase 2Active Not Recruiting

Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.

Role: lead

NCT06525272Phase 1Not Yet Recruiting

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy

Role: lead

NCT06355479Phase 3Completed

A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

Role: lead

NCT05315921Phase 1Unknown

Study of OsrhAAT or Placebo in Healthy Volunteers

Role: lead

NCT04835480Phase 2Recruiting

A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

Role: lead

NCT04384523Phase 1Completed

A Study of OsrHSA in Adult Healthy Male and Female Volunteers

Role: lead

All 7 trials loaded